Virus News and Research

Latest Virus News and Research

Researchers study molecular mechanisms in early stages of IPN virus infection

Infectious pancreatic necrosis is a serious disease that leads to enormous losses in the salmon industry each year. The virus that causes the disease, IPN, is very prevalent in farmed salmon and trout in Norway. The virus attacks a wide diversity of hosts and has been found to occur in many different fish species, in addition to shellfish and molluscs.

30 Dec 2010

New study confirms pancreas disease infects horizontally from population to population in seawater phase

Researchers and the salmon industry have been debating whether fingerling from freshwater farms can be a source of the virus that causes pancreas disease: salmonid alfavirus. The results of a new doctoral study show that this is not the case: pancreas disease transmits horizontally in the seawater phase and infection in fresh water has little bearing on how the disease spreads.

29 Dec 2010

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.

29 Dec 2010

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy. CEL-SCI has now completed all of the manufacturing and regulatory requirements to begin enrollment of the study.

29 Dec 2010

Molecular interaction between structural HCV protein and protein critical to viral replication identified

Scientists from the Florida campus of The Scripps Research Institute have identified a molecular interaction between a structural hepatitis C virus protein (HCV) and a protein critical to viral replication. This new finding strongly suggests a novel method of inhibiting the production of the virus and a potential new therapeutic target for hepatitis C drug development.

29 Dec 2010

Study sheds light on how bacteria developed resistance to antibiotics

Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, is uncovering the secrets of one of nature's most primitive immune systems.

27 Dec 2010

Flu infection rates double in a week

Figures reveal that the rates of flu infection in the UK have more than doubled in the last week. Number of cases has risen to 87.1 per 100,000 people, from 32.8 in the previous week, according to the Royal College of GPs. Reports also reveal that school-age children from England and Wales are particularly affected. Ages five to 14 are highest affected followed by those under four, then people aged 15 to 44. Considering all age groups rates almost tripled in the South in one week, from 36 per 100,000 to 93.4. In the North, the rate was 55.5, up from 15.7, and was 94.9 in the central England region, up from 37.9.

27 Dec 2010

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Scientific American examines how, in an attempt to improve early recognition of viruses that could give rise to pandemics in people, such as last year's H1N1 swine flu, scientists are looking to better understand "the viruses that infect the estimated 941 million domesticated pigs around the world." However, as the article notes, "[i]ntensive monitoring of pig viruses is unlikely to come any time soon … Most pork-producing countries do not test their pigs at all, and in some that do - such as the U.S. - the testing is done on behalf of the pork producers.

24 Dec 2010

Discovery highlights potential to combat HIV/AIDS

Researchers at the University of Minnesota have discovered how HIV binds to and destroys a specific human antiviral protein called APOBEC3F. The results suggest that a simple chemical change can convert APOBEC3F to a more effective antiviral agent and that shielding of a common feature shared by related proteins may yield a similar outcome.

23 Dec 2010

EPA to clean up vector-breeding site to eliminate dengue epidemic

To control the severe dengue epidemic, the Environmental Protection Administration (EPA) said the first priority is to locate diagnosed patients and eliminate virus-carrying mosquitoes, the vectors of Dengue fever, and called on all people to clean up mosquito breeding sites.

23 Dec 2010

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Novavax, and scientists at the University of Massachusetts Medical School, led by Dr. Trudy Morrison, published in the January 2011 issue of The Journal of Virology, a report indicating that a novel virus-like particle vaccine candidate against respiratory syncytial virus (RSV) protects mice from a live virus challenge.

23 Dec 2010

Medicago completes first part of H5N1 vaccine Phase II trial

Medicago, a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that the last dose of vaccine has been administered completing the first part of the Company's Phase II human clinical trial with its H5N1 Avian Influenza vaccine.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

NanoViricides, Inc., announced today that it had consummated a closing with Seaside 88, LP ("Seaside"), a Florida limited partnership, on Seaside's purchase of an additional $2.5M of the Company's Series B Convertible Preferred Stock. Seaside has financed several leading-edge bio-pharma companies, including Cytori Therapeutics, Inc., Generex Biotechnology Corporation, and NovaDel Pharma, Inc. among others.

22 Dec 2010

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

Critically ill and disadvantaged children are counting on the generosity of strangers Thursday, December 23, 2010, asking for 100,000 votes to help win their grant ideas in the December Pepsi Refresh Project. Securing the thousands of votes needed to finish in winning spots is an uphill challenge for many organizations, but eight enterprising charities have joined forces to help each other into the winners circle.

22 Dec 2010

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

22 Dec 2010

Biogen Idec, Elan propose updated product labeling for TYSABRI to FDA and EMA

Biogen Idec and Elan Corporation, plc announced that the companies have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) to request review and approval to update the respective TYSABRI Prescribing Information and Summary of Product Characteristics.

22 Dec 2010

Expansion of HIV screening worthwhile

According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.

21 Dec 2010

Chronic fatigue syndrome not linked to virus

The latest research from the University College London, the Wellcome Trust Sanger Institute, and University of Oxford, England suggests that chronic fatigue syndrome (CFS) is not caused by the virus XMRV (xenotropic murine leukemia virus-related virus). The team says that earlier research that linked the virus to CFS was faulty because of contamination of mouse cell DNA samples in the laboratory.

21 Dec 2010

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

Virus News and Research

Latest Virus News and Research

Researchers study molecular mechanisms in early stages of IPN virus infection

New study confirms pancreas disease infects horizontally from population to population in seawater phase

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

Molecular interaction between structural HCV protein and protein critical to viral replication identified

Study sheds light on how bacteria developed resistance to antibiotics

Flu infection rates double in a week

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Discovery highlights potential to combat HIV/AIDS

EPA to clean up vector-breeding site to eliminate dengue epidemic

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Medicago completes first part of H5N1 vaccine Phase II trial

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

Biogen Idec, Elan propose updated product labeling for TYSABRI to FDA and EMA

Expansion of HIV screening worthwhile

Chronic fatigue syndrome not linked to virus

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in